pwc glp 1 What is the future of GLP-1 trends: PwC stops covering GLP-1s for

They can ache, itch and sometimes need surgery

People with obesity tend to have a poorer response to some disease-modifying therapies, particularly older first-line treatments, compared with people at a healthier weight, she says

While some studies suggest that carnitine may not significantly improve athletic performance, the side effects of L-carnitine, particularly the cardiovascular risks, warrant caution

Pernicious anaemia (an autoimmune condition affecting B12 absorption) is a common cause of B12 deficiency that requires specific testing for anti-intrinsic factor antibodies

Overall prescribing trends The study found that 1,970,374 patients were prescribed a GLP-1 RA between January 2018 and March 2025, with 9,376,686 total prescriptions during this period